Skip to main content
. 2019 Dec 24;10:2964. doi: 10.3389/fimmu.2019.02964

Figure 1.

Figure 1

Finnish sarcoidosis patients. Selection criteria based on sarcoidosis prognosis and the presence or absence of the HLA markers (HLA-DRB1*03:01 and/or HLA-DRB1*04:01-DPB1*04:01 haplotype). From each of the HLA positive/negative groups, 18 samples were randomly selected for this study.